| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Benjamin Barbash, Dhruv Mehta, Mohamed Tausif Siddiqui, Lavneet Chawla, Brad Dworki. Impact of Cannabinoids on Symptoms of Refractory Gastroparesis: A Single-center Experience. Cureus. vol 11. issue 12. 2020-09-28. PMID:31993268. |
the 'gastroparesis cardinal symptom index' (gcsi) and an analog scale rating abdominal pain were applied to prospectively assess the effect of cannabinoids, in the form of dronabinol and medical cannabis, on refractory gastroparesis symptoms. |
2020-09-28 |
2023-08-13 |
Not clear |
| Tal Gonen, Howard Amita. Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases. Rambam Maimonides medical journal. vol 11. issue 1. 2020-09-28. PMID:32017684. |
cannabis and cannabinoids in the treatment of rheumatic diseases. |
2020-09-28 |
2023-08-13 |
Not clear |
| Tal Gonen, Howard Amita. Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases. Rambam Maimonides medical journal. vol 11. issue 1. 2020-09-28. PMID:32017684. |
cannabis and cannabinoids are currently being studied due to their potential as analgesics. |
2020-09-28 |
2023-08-13 |
Not clear |
| Tal Gonen, Howard Amita. Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases. Rambam Maimonides medical journal. vol 11. issue 1. 2020-09-28. PMID:32017684. |
in this review we will discuss current literature regarding cannabinoids and cannabis as treatment for rheumatic diseases. |
2020-09-28 |
2023-08-13 |
Not clear |
| Tal Gonen, Howard Amita. Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases. Rambam Maimonides medical journal. vol 11. issue 1. 2020-09-28. PMID:32017684. |
treatment of this syndrome is symptomatic, and it has been suggested that cannabis and cannabinoids could potentially alleviate some of the symptoms associated with fibromyalgia. |
2020-09-28 |
2023-08-13 |
Not clear |
| Tal Gonen, Howard Amita. Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases. Rambam Maimonides medical journal. vol 11. issue 1. 2020-09-28. PMID:32017684. |
however, data on long-term efficacy and safety of cannabinoid and cannabis use are still lacking. |
2020-09-28 |
2023-08-13 |
Not clear |
| Tal Gonen, Howard Amita. Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases. Rambam Maimonides medical journal. vol 11. issue 1. 2020-09-28. PMID:32017684. |
cannabinoids and cannabis are commonly investigated as analgesic agents, but in recent years more evidence has accumulated on their potential immune-modulatory effect, supported by results in animal models of certain rheumatic diseases. |
2020-09-28 |
2023-08-13 |
Not clear |
| Tal Gonen, Howard Amita. Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases. Rambam Maimonides medical journal. vol 11. issue 1. 2020-09-28. PMID:32017684. |
while results that demonstrate the same effect in humans are still lacking, cannabinoids and cannabis remain potential drugs to alleviate the pain associated with rheumatic diseases, as they were shown to be safe and to cause limited adverse effects. |
2020-09-28 |
2023-08-13 |
Not clear |
| Jeffrey Y Hergenrather, Joshua Aviram, Yelena Vysotski, Salvatore Campisi-Pinto, Gil M Lewitus, David Meir. Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients. Rambam Maimonides medical journal. vol 11. issue 1. 2020-09-28. PMID:32017685. |
cannabinoid and terpenoid doses are associated with adult adhd status of medical cannabis patients. |
2020-09-28 |
2023-08-13 |
Not clear |
| Sivan Ritter, Lilach Zadik-Weiss, Osnat Almogi-Hazan, Reuven O. Cannabis, One Health, and Veterinary Medicine: Cannabinoids' Role in Public Health, Food Safety, and Translational Medicine. Rambam Maimonides medical journal. vol 11. issue 1. 2020-09-28. PMID:32017686. |
cannabis, one health, and veterinary medicine: cannabinoids' role in public health, food safety, and translational medicine. |
2020-09-28 |
2023-08-13 |
human |
| Michael A Überal. A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain. Journal of pain research. vol 13. 2020-09-28. PMID:32104061. |
as the endocannabinoid system is known to control pain at peripheral, spinal, and supraspinal levels, interest in medical use of cannabis is growing. |
2020-09-28 |
2023-08-13 |
Not clear |
| Michael A Überal. A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain. Journal of pain research. vol 13. 2020-09-28. PMID:32104061. |
a proprietary blend of cannabis plant extracts containing delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd) as the principal cannabinoids is formulated as an oromucosal spray (usan name: nabiximols) and standardized to ensure quality, consistency and stability. |
2020-09-28 |
2023-08-13 |
Not clear |
| Marco Colizzi, Sarah Tosato, Mirella Rugger. Cannabis and Cognition: Connecting the Dots towards the Understanding of the Relationship. Brain sciences. vol 10. issue 3. 2020-09-28. PMID:32120842. |
in summary, the evidence suggests that earlier age of use, high-frequency and high-potency cannabis use, as well as sustained use over time and use of synthetic cannabinoids, are all correlated with a higher likelihood of developing potentially severe and persistent executive function impairments. |
2020-09-28 |
2023-08-13 |
Not clear |
| Abhilash Perisetti, Afrina Hossain Rimu, Salman Ali Khan, Pardeep Bansal, Hemant Goya. Role of cannabis in inflammatory bowel diseases. Annals of gastroenterology. vol 33. issue 2. 2020-09-28. PMID:32127734. |
cannabis comprises more than 70 aromatic hydrocarbon compounds known as cannabinoids. |
2020-09-28 |
2023-08-13 |
human |
| Anmi Jose, Levin Thomas, Gayathri Baburaj, Murali Munisamy, Mahadev Ra. Cannabinoids as an Alternative Option for Conventional Analgesics in Cancer Pain Management: A Pharmacogenomics Perspective. Indian journal of palliative care. vol 26. issue 1. 2020-09-28. PMID:32132797. |
the treatment of medical conditions with cannabis and cannabinoid compounds is constantly expanding. |
2020-09-28 |
2023-08-13 |
Not clear |
| Fabrizio Calapai, Luigi Cardia, Emanuela Elisa Sorbara, Michele Navarra, Sebastiano Gangemi, Gioacchino Calapai, Carmen Mannucc. Cannabinoids, Blood-Brain Barrier, and Brain Disposition. Pharmaceutics. vol 12. issue 3. 2020-09-28. PMID:32183416. |
potential therapeutic actions of the cannabinoids delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd) are based on their activity as analgesics, anti-emetics, anti-inflammatory agents, anti-seizure compounds. |
2020-09-28 |
2023-08-13 |
Not clear |
| David B Finlay, Kathleen J Sircombe, Mhairi Nimick, Callum Jones, Michelle Glas. Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors. Frontiers in pharmacology. vol 11. 2020-09-28. PMID:32269529. |
terpenoids from cannabis do not mediate an entourage effect by acting at cannabinoid receptors. |
2020-09-28 |
2023-08-13 |
Not clear |
| Chad Walkade. A case study for the use of medical cannabis in generalized anxiety disorder. Discoveries (Craiova, Romania). vol 7. issue 2. 2020-09-28. PMID:32309610. |
research on the health effects of cannabis and cannabinoids has been limited worldwide, leaving patients, health care professionals, and policymakers without the evidence they need to make sound decisions regarding the use of cannabis and cannabinoids. |
2020-09-28 |
2023-08-13 |
Not clear |
| Farjana Afrin, Mengna Chi, Andrew L Eamens, Ryan J Duchatel, Alicia M Douglas, Jennifer Schneider, Craig Gedye, Ameha S Woldu, Matthew D Du. Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer. Cancers. vol 12. issue 4. 2020-09-28. PMID:32340151. |
low-thc cannabis and non-thc cannabinoids for the treatment of cancer. |
2020-09-28 |
2023-08-13 |
Not clear |
| Ana I Fraguas-Sánchez, Ana I Torres-Suárez, Marie Cohen, Florence Delie, Daniel Bastida-Ruiz, Lucile Yart, Cristina Martin-Sabroso, Ana Fernández-Carballid. PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment. Pharmaceutics. vol 12. issue 5. 2020-09-28. PMID:32397428. |
cannabidiol (cbd), the main nonpsychotropic cannabinoid, appears as a potential anticancer drug. |
2020-09-28 |
2023-08-13 |
Not clear |